Valo Health closes $190m Series B led by PSP Investments
Boston-based Valo Health, a technology company that uses human-centric data and machine learning for drug discovery and development, has closed a $190 million Series B financing.
Boston-based Valo Health, a technology company that uses human-centric data and machine learning for drug discovery and development, has closed a $190 million Series B financing.
Copyright PEI Media
Not for publication, email or dissemination
